Back
VistaGen Therapeutics, Inc. VTGN · Insights
VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical entity dedicated to advancing and ... Price0.1844
Market Cap8.09 M
Float44.88 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro